Hematology

Clinical Lymphoma, Myeloma & Leukemia

Editor in Chief: Sundar Jagannath, MD, <br/>Hagop Kantarjian, MD, <br/>Sagar Lonial, MD, <br/>Owen A. O’Connor, MD

Organizational Affiliations: International Myeloma Society and the Society of Hematologic Oncology European Society for Medical Oncology

Clinical Lymphoma, Myeloma & Leukemia is the only journal of its clinical scope published in the United States. It includes articles on lymphoma, myeloma, and leukemias such as AML, ALL, CML, CLL, MDS and MPD. Clinical Lymphoma, Myeloma & Leukemia is a peer-reviewed bimonthly journal established in 2000. It features an international editorial board comprised of prominent thought leaders including Senior Editor-in-Chief Sundar Jagannath and Editors- in-Chief Dr. Owen O'Connor, Dr. Sagar Lonial and Dr. Hagop Kantarjian. Each issue is mailed free of charge to US-based medical oncologists and hematologists. Each issue of Clinical Lymphoma, Myeloma & Leukemia features original contributions, invited comprehensive reviews, and current trial reports, as well as meeting highlights and reports taken from major oncology meetings throughout the year. Also included are brief editorials of current news and the latest topics concerning lymphoma, myeloma and leukemia for clinicians.

Global Print Circulation

10,001

Avg. Global Monthly Visits

12,202

Avg. Global Monthly Unique Visitors

9,862

Avg. Global Monthly Page Views

23,007

Avg. Global eTOC Distribution

13,943

Circulation updated on February 27, 2023, based on December 2022 BPA Brand Report., eTOC Metrics: 6 Month Average of eTOC sends - Nov 2022 to April 2023,